Diabetes and Ramadan: Utility of flash-glucose monitoring derived markers of glycaemic control and comparison with glycosylated haemoglobin.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 02 03 2019
accepted: 20 05 2019
pubmed: 1 6 2019
medline: 13 11 2019
entrez: 1 6 2019
Statut: ppublish

Résumé

Flash glucose monitoring (FGM)-derived markers of glucose control and variability and laboratory measured HbA1c among patients with diabetes on insulin in context of Ramadan fasting (RF) were examined and compared. FGM data on insulin-treated patients (n = 20, age 42.3 ± 11.4 years; 18 male, 2 female; 13 with type 1 and 7 with type 2 diabetes) who fasted during Ramadan were used to calculate Q-score as an indicator of glycaemia before, during and after RF. Post-hoc analysis in a group of patients (n = 12) who had HbA1c available and appropriate for these periods was performed. Other relevant data were extracted from patient records. Mean glucose (9.6 ± 1.32 v 10.78 ± 1.64 mmol/l; P < 0.0001) and Q-score increased significantly with Ramadan fasting and reduced after Ramadan. Post-hoc subgroup analysis showed a significant rise in eA1c (7.2 ± 0.4%; 55.0 ± 4.4 mmol/mol v 7.7 ± 0.5%; 61.0 ± 5.5 mmol/mol) but not in laboratory HbA1c with Ramadan fasting; eA1c reduced after Ramadan (P = 0.018). Ramadan fasting was associated with a deterioration in overall glucose control and time in hyperglycaemia in insulin-treated patients. FGM-derived markers are useful and a preferable alternative to HbA1c in Ramadan studies.

Identifiants

pubmed: 31150718
pii: S0168-8227(19)30327-4
doi: 10.1016/j.diabres.2019.05.020
pii:
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150-156

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Ilham Saadane (I)

Imperial College London Diabetes Centre, Research Department, Abu Dhabi, United Arab Emirates. Electronic address: isaadane@icldc.ae.

Tanveer Ashraf (T)

Imperial College London Diabetes Centre, Research Department, Abu Dhabi, United Arab Emirates. Electronic address: tashraf@icldc.ae.

Tomader Ali (T)

Imperial College London Diabetes Centre, Research Department, Abu Dhabi, United Arab Emirates. Electronic address: tfali@icldc.ae.

Nader Lessan (N)

Imperial College London Diabetes Centre, Research Department, Abu Dhabi, United Arab Emirates. Electronic address: nlessan@icldc.ae.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH